
IndraLab
Statements
5Z-7-oxozeaenol inhibits MAP3K7. 16 / 16
|
16
reach
"One such compound is 5Z-7-oxozeaenol, which selectively inhibits TAK-1 and has been shown to reduce inflammation and enhance the sensitivity of breast and pancreatic cancer cells to various chemotherapeutic agents, further highlighting the central role that IRAK signaling plays in chemotherapy resistance."